Showing results (291-300 of 326) with videos related to

Sort By:
Pageof 33
Cancer|April 29, 1998
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group BB L Samuels, J E Herndon, D C Harmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
AMOPLACE treatment of intermediate-grade and high-grade malignant lymphoma: a Cancer and Leukemia Group B studyB A Parker, M Santarelli, M R Green, et al.
Psychotherapy and Psychosomatics|January 1, 1994
Quality of life in patients with limited small-cell carcinoma of the lung receiving chemotherapy with or without radiation therapy, for cancer and leukemia group BT A Ahles, P M Silberfarb, A C Rundle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group BM P Kosty, S B Fleishman, J E Herndon, et al.
Lung Cancer (Amsterdam, Netherlands)|March 8, 2000
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532M C Perry, D C Ihde, J E Herndon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering resultsO S Breathnach, B Freidlin, B Conley, et al.
The EMBO Journal|January 1, 1991
Mammalian nuclei contain foci which are highly enriched in components of the pre-mRNA splicing machineryM Carmo-Fonseca, D Tollervey, R Pepperkok, et al.
Nature|June 23, 2000
Redundant roles for the TFIID and SAGA complexes in global transcriptionT I Lee, H C Causton, F C Holstege, et al.
The New England Journal of Medicine|November 19, 1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVDG P Canellos, J R Anderson, K J Propert, et al.
Cancer|June 1, 1997
Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group BN J Yogelzang, J E Herndon, C Cirrincione, et al.
Pageof 33